Alendronate Sodium reduces the amount of calcium lost from bones and increases the density of bones.
Osteoclasts cause bone reabsorption.
Alendronate Sodium inhibits osteoclast production thereby lessening reabsorbtion and causing an increase in bone density. It is used for the treatment of osteoporosis and Paget's Disease. For the treatment of osteoporosis, the recommended daily dose is 10mg. For the prevention of osteoporosis the recommended dose is 5mg daily. And for the treatment of Paget's Disease the dose recommended is 40mg daily for 6 months.